Verastem | VSTM - Trade Debtors


Verastem reported $10.36M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Alaunos Therapeutics USD 2K 0 Jun/2025
AstraZeneca USD 18.86B 972M Jun/2026
Curis USD 2.55M 400K Jun/2024
Cytokinetics USD 6.83M 10.94M Mar/2026
Gilead Sciences USD 5.06B 314M Jun/2026
Incyte USD 1.13B 73.7M Jun/2026
Laboratory Of America USD 2.5B 54.3M Jun/2026
Novartis USD 9.85B 252M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
TG Therapeutics USD 401.56M 9.52M Jun/2026
Verastem USD 10.36M 1.34M Mar/2026